Arbutus Biopharma
ABUS
ABUS
111 hedge funds and large institutions have $152M invested in Arbutus Biopharma in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 22 closing their positions.
Holders
111
Holders Change
-11
Holders Change %
-9.02%
% of All Funds
1.75%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
38
Reduced
30
Closed
22
Calls
$2.34M
Puts
$1.13M
Net Calls
+$1.21M
Net Calls Change
-$2.8M
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$5.28M |
2 |
2
BlackRock
New York
|
$22.9M |
3 |
TSC
3
Two Seas Capital
Rye,
New York
|
$19M |
4 |
WCM
4
Whitefort Capital Management
New York
|
$18.6M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.98M |